LABORATORY DIAGNOSTIC ALGORITHMS FOR COVID-19

I. Dziublyk, O. Bororova, G. Kapitan, O. Yakovenko
{"title":"LABORATORY DIAGNOSTIC ALGORITHMS FOR COVID-19","authors":"I. Dziublyk, O. Bororova, G. Kapitan, O. Yakovenko","doi":"10.31215/2306-4927-2022-30-2-63-71","DOIUrl":null,"url":null,"abstract":"The novel coronavirus SARS-CoV-2 causes respiratory diseases in humans, in particular acute respiratory disease COVID-19 (Coronavirus disease 2019), and can be transmitted from person to person. Specific antiviral therapy has not been developed completely. Various vaccines are widely introduced in the world. Non-specific prophylaxis, aimed at preventing the spread of the SARS-CoV-2 virus, is carried out in relation to the source of the infectious agent (patient or virus carrier), the mechanisms of transmission of the virus and the protection of contact person. During a pandemic, testing for SARS-CoV-2 is a very important part of the first line defense of the population from COVID-19 in any country of the world. It is timely testing that makes it possible to identify and isolate an infected person, slow down the transmission of coronavirus and provide targeted care to the patients. Diagnostic testing for SARS-CoV-2 is considered a very important component of the overall COVID-19 prevention and control strategy. WHO strongly recommends to test individuals suspected of having a COVID-19 immediately or as early as possible to confirm or rule out SARS-CoV-2 infection. The rapid spread of COVID-19 poses a whole list of critical tasks in front of healthcare professionals, the solution of which is closely related to the introduction of effective etiological diagnostics, including the use of rapid tests. For the safe and high-quality use of rapid tests, it is important to have a basic understanding of how they work, what are their advantages and disadvantages, what are the algorithms for their use, where is their place in the etiological diagnosis of COVID-19, and how to record correctly the results and to draw conclusions. The article sets out the requirements for the use of rapid tests based on immunochromatographic analysis and the procedure for testing for COVID-19 based on WHO materials, analysis of domestic and foreign scientific publications, regulatory documents and orders of the Ministry of Health of Ukraine. Key words: COVID-19, SARS-CoV-2, diagnostics, rapid tests, nucleic acid amplification method.","PeriodicalId":328937,"journal":{"name":"Ukrainian Pulmonology Journal","volume":"81 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ukrainian Pulmonology Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31215/2306-4927-2022-30-2-63-71","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

The novel coronavirus SARS-CoV-2 causes respiratory diseases in humans, in particular acute respiratory disease COVID-19 (Coronavirus disease 2019), and can be transmitted from person to person. Specific antiviral therapy has not been developed completely. Various vaccines are widely introduced in the world. Non-specific prophylaxis, aimed at preventing the spread of the SARS-CoV-2 virus, is carried out in relation to the source of the infectious agent (patient or virus carrier), the mechanisms of transmission of the virus and the protection of contact person. During a pandemic, testing for SARS-CoV-2 is a very important part of the first line defense of the population from COVID-19 in any country of the world. It is timely testing that makes it possible to identify and isolate an infected person, slow down the transmission of coronavirus and provide targeted care to the patients. Diagnostic testing for SARS-CoV-2 is considered a very important component of the overall COVID-19 prevention and control strategy. WHO strongly recommends to test individuals suspected of having a COVID-19 immediately or as early as possible to confirm or rule out SARS-CoV-2 infection. The rapid spread of COVID-19 poses a whole list of critical tasks in front of healthcare professionals, the solution of which is closely related to the introduction of effective etiological diagnostics, including the use of rapid tests. For the safe and high-quality use of rapid tests, it is important to have a basic understanding of how they work, what are their advantages and disadvantages, what are the algorithms for their use, where is their place in the etiological diagnosis of COVID-19, and how to record correctly the results and to draw conclusions. The article sets out the requirements for the use of rapid tests based on immunochromatographic analysis and the procedure for testing for COVID-19 based on WHO materials, analysis of domestic and foreign scientific publications, regulatory documents and orders of the Ministry of Health of Ukraine. Key words: COVID-19, SARS-CoV-2, diagnostics, rapid tests, nucleic acid amplification method.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19实验室诊断算法
新型冠状病毒SARS-CoV-2可导致人类呼吸道疾病,特别是急性呼吸道疾病COVID-19(冠状病毒病2019),并可在人与人之间传播。特异性抗病毒治疗尚未完全开发出来。世界上各种各样的疫苗被广泛引进。针对SARS-CoV-2病毒的传染源(患者或病毒携带者)、病毒传播机制和接触者的保护,采取非特异性预防措施,以防止该病毒的传播。在大流行期间,对SARS-CoV-2进行检测是世界上任何国家人口免受COVID-19的第一线防御的一个非常重要的部分。只有及时的检测才能识别和隔离感染者,减缓冠状病毒的传播,并为患者提供有针对性的护理。SARS-CoV-2诊断检测被认为是整个COVID-19防控战略的一个非常重要的组成部分。世卫组织强烈建议立即或尽早对疑似感染COVID-19的个人进行检测,以确认或排除SARS-CoV-2感染。COVID-19的快速传播给医护人员提出了一系列关键任务,解决这些任务与引入有效的病原学诊断密切相关,包括使用快速检测。为了安全、高质量地使用快速检测,重要的是要基本了解快速检测的工作原理、优缺点、使用算法、在COVID-19病原学诊断中的地位,以及如何正确记录结果并得出结论。本文阐述了基于免疫层析分析的快速检测方法的使用要求,以及基于世卫组织材料、国内外科学出版物分析、监管文件和乌克兰卫生部命令的COVID-19检测程序。关键词:COVID-19, SARS-CoV-2,诊断,快速检测,核酸扩增法
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
PECULIARITIES OF THE COURSE OF COPD IN PATIENTS WITH DIFFERENT A46G (RS1042713) ALLELES OF ADRB2 GENE IDIOPATHIC PULMONARY FIBROSIS AND PROGRESSIVE PULMONARY FIBROSIS IN ADULTS: ADAPTED EVIDENCE-BASED CLINICAL GUIDELINE (DRAFT) TRAUMATIC PNEUMONITIS DUE TO COMBAT CHEST INJURY AS A RISK FACTOR FOR PNEUMONIA COMPUTED TOMOGRAPHY DENSITOMETRY OF THE LUNGS IN THE ALGORITHM FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASES, INCLUDING OCCUPATIONAL AND ECOLOGICAL DISEASES THE CASE OF COVID-19 WITH ATYPICAL PULMONARY LESIONS AND A LIFETIME HISTOLOGICAL EXAMINATION
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1